Linkage and segregation analysis have shown that circulating angiotensin-I converting enzyme (ACE) levels are influenced by a major quantitative trait locus that maps within or close to the ACE gene. The D variant of a 287 bp insertion/deletion (I/D) polymorphism in intron 16 of the gene is associated with high ACE levels and may also be related to increased risk of cardiovascular disease. Multiple variants that are in linkage disequilibrium with the I/D polymorphism have been described, but it is unknown if any of these are directly implicated, alone or in combination with as yet undiscovered variants, in the determination of ACE levels. An analysis of 10 polymorphisms spanning 26 kb of the ACE gene revealed a limited number of haplotypes in Caucasian British families due to strong linkage disequilibrium operating over this small chromosomal region. A haplotype tree (cladogram) was constructed with three main branches (clades A-C) which account for 90% of the observed haplotypes. Clade C is most likely derived from clades A and B following an ancestral recombination event. This evolutionary information was then used to direct a series of nested, measured haplotype analyses that excluded upstream sequences, including the ACE promoter, from harbouring the major ACE-linked variant that explains 36% of the total trait variability. Residual familial correlations were highly significant, suggesting the influence of additional unlinked genes. Our results demonstrate that a combined cladistic/measured haplotype analysis of polymorphisms within a gene provides a powerful means to localize variants that directly influence a quantitative trait.
INTRODUCTION
The analysis of multiple polymorphisms in a candidate gene or region and the definition of their relationship to the underlying susceptibility or quantitative trait locus (QTL) represents a major theoretical and practical bottleneck in the identification of DNA variants underlying complex inherited diseases and traits. The angiotensin-I converting enzyme (ACE) is strongly influenced by a limited number of QTLs and is an experimentally tractable model trait for the development of strategies for identifying such variants. Physiological, pharmacological and genetic studies have all shown the importance of ACE and its inhibition in the pathogenesis and treatment of a variety of cardiovascular diseases (1) (2) (3) (4) (5) (6) (7) . Therefore, there is considerable interest in defining the molecular mechanisms determining circulating ACE levels in humans.
Evidence that circulating ACE levels are under substantial genetic control was first detected in a segregation analysis of ACE levels in 87 healthy nuclear families (8) . Familial correlations showed a striking pattern that was consistent with a QTL influencing plasma ACE levels. The human ACE gene has been cloned and localized to chromosome 17q23 (9) and a 287 bp insertion/deletion (I/D) polymorphism in intron 16 has been identified for use as a genetic marker (10) . A population-based analysis of unrelated individuals with the I/D polymorphism showed an association between this polymorphism and plasma ACE levels. The association followed an additive pattern with D/D and I/I genotypes being associated with high and low ACE levels, respectively, and I/D heterozygotes being associated with an intermediate level (10) . These associations have been confirmed in family studies in white European (11) and AfroCaribbean (12) populations. Linkage between the QTL and a neighbouring microsatellite marker has been detected and alternative models incorporating an unlinked genetic component have also been investigated (12) .
Following a sequencing study, Villard et al. (13) reported a series of polymorphisms within the ACE gene and investigated the pattern of linkage disequilibrium both among the polymorphisms and between the polymorphisms and what they refer to as one or two ACE-linked QTLs. They proposed that two variants influence circulating ACE levels: one that could be in complete linkage disequilibrium or identical with the I/D polymorphism and a second that mapped upstream of the start of translation of the ACE gene. 
Here we report the results of a haplotype analysis with 10 polymorphisms at the ACE locus that were genotyped in a series of white British families. An evolutionary tree (cladogram) was proposed which accounted for the majority (90%) of the observed haplotypes. Information from the cladogram was then used to direct a nested, measured haplotype analysis of plasma ACE levels and to investigate both the number of variants influencing the ACE quantitative trait and their likely location.
RESULTS

Cladistic haplotype analysis
Haplotypes of 10 biallelic polymorphisms, distributed throughout the ACE gene ( Fig. 1) , were assigned to 555 members of 83 extended families by following a novel two-stage procedure. Firstly, genotype data were repeatedly run through the SIM-WALK program (14) to compile a list of every possible set of haplotypes for each family that included no recombination events. In 24 families a unique set of haplotypes was found, but in other families as many as 48 alternative haplotype sets (with zero recombinants) were found to be consistent with the genotypic data. In the second stage, the haplotype data were subjected to a maximum likelihood analysis in order to estimate the haplotype frequencies in the founders. Haplotype sets with small final probabilities (<10 -6 ) were eliminated from further analysis, leaving 239 non-recombinant haplotype sets to enter into the measured haplotype analysis.
The seven most frequent haplotypes, which cumulatively account for 90% of the founders' haplotypes, are listed in Table  1 (a complete listing of the haplotypes is available from the World Wide Web at http://www.well.ox.ac.uk/mfarrall ). The polymorphisms are all in strong linkage disequilibrium; sparse contingency tables analyses, testing each polymorphism in turn for association with haplotypes constructed from the remaining polymorphisms, were all highly significant (P < 0.001). The 95% confidence interval for the expected number of different haplotypes in 183 unrelated individuals using the observed gene frequencies and assuming linkage equilibrium is 267-295 (versus the 29 found for the 183 founders).
The two most frequent haplotypes, haplotype 1 (T-A-T-A-T-T-G-I-A-3) and haplotype 2 (C-C-C-T-C-C-A-D-G-2), complement each other at all 10 sites. Haplotype 3 (T-A-T-A-T-C-A-D-G-2) is consistent with being generated by an ancestral recombination event between haplotype 2 and haplotype 1, 5 or 7 with a breakpoint in the interval delimited by T-93C and T1237C. Haplotypes 5 (T-A-T-A-T-C-G-I-A-3) and 7 (T-A-T-A-T-T-A-I-A-3) each show one difference from haplotype 1 at the T1237C and G2215A markers, respectively; these differences are presumably due to spontaneous mutations. Haplotype 6 (C-C-C-T-C-C-G-D-G-2) shows one difference from haplotype 2 at the G2215A marker. Haplotype 4 (T-A-C-A-T-C-A-D-G-2) shows one difference from haplotype 3 at the T-3892C marker.
Following the principle of maximum parsimony, we propose a putative haplotype tree linking haplotypes 1-7, which is illustrated in Figure 2 . Three closely related branches (clades) are proposed: A, comprising haplotypes 1, 5 and 7; B, comprising haplotypes 2 and 6; and C, comprising haplotypes 3 and 4. The other rare haplotypes were pooled into a common group (X) for subsequent analyses.
Measured haplotype analysis
The results of a pedigree analysis, to estimate by maximum likelihood the influence of each haplotype on the ACE quantitat- ive trait, are shown in Table 2 . Additive (co-dominant) models were fitted, as supplementary analyses showed no significant support for a dominance variance component (data not shown). The most general model ([1, 2, 3, 4, 5, 6, 7, X]) includes seven haplotype-specific parameters to model the mean effect on the ACE quantitative trait for each haplotype shown in Table 1 and a single parameter to model the common effect for all the other haplotypes (group X). Residual familial correlations that were not accounted for by the ACE-linked effects were modelled by following a class D regressive approach (15) .
The It is important to consider alternative molecular mechanisms to explain how haplotype 3 arose. A gene conversion or double recombination event involving the transfer of a continuous segment of at least 6 kb of DNA, including the five polymorphisms that map upstream of the ACE promoter, from clade A to haplotype 2 cannot be excluded from consideration. Under this scenario, the major variant influencing ACE levels could then be located upstream of the ACE gene. However, at least 6 kb of sequence including the ACE promoter would then be excluded from harbouring the major variant influencing ACE levels.
In our data, haplotypes 4-7 each showed a single internal difference with haplotypes 1, 2 and 3 and could therefore be assigned to one of the three clades, adhering to the principle of maximum parsimony. Several rare haplotypes not listed in Table  1 could also be assigned to one of the three clades. We have not measured the individual effects of these haplotypes on ACE levels as the numbers of phenotyped subjects carrying these haplotypes is too small for a meaningful analysis, but instead we pooled all rare haplotypes into group X.
The finding of a limited number of clades provides a boundary for the potential model space that should be explored in attempts to structure the underlying variation that directly influences ACE levels. Consider two alternative models, a single variant model and a two variant model with one variant on either side of the ancestral breakpoint. For the single variant model, we may suppose that clade A carries a low trait allele and clade B carries a high trait allele. We then directly test the location of the variant relative to the ancestral breakpoint in a nested statistical analysis. For the two variant model, we suppose that clade A carries two low trait alleles, clade B carries two high trait alleles and clade C one low and one high trait allele. If we assume that one variant shows no dominance over the other (this assumption has been confirmed in supplementary analyses and it is also evident from an inspection of the A/A, A/B and B/B genotype means shown in Table 3 ), then we would expect that clade C would have an effect on the ACE trait which is intermediate between the effects of clades A and B. The results from the measured haplotype analysis (Table 2 and 3) show that clade C very closely resembles clade B in its influence on ACE levels. We therefore conclude that the major variant influencing the ACE levels is located downstream of the ancestral breakpoint and that there is no significant variant in the promoter or other upstream sequences. Thus, the finding of Villard et al. (13) of a major ACE variant mapping to the promoter region is not confirmed by our study. We suggest that analysis of their data by the methods presented here might be helpful.
An alternative statistical test for other variants at the ACE locus is provided by a comparison of models [A, B, C, X] and [A, B5C, X]. This test shows that there is no support (P > 0.05) for an additional variant mapping upstream of the promoter. We also note that the polymorphisms T1237C and G2215A appear in their alternative states in members of clades A and B, which makes them very unlikely to be the downstream major ACE variant. The I/D, G2350A and 4656(CT) 3/2 polymorphisms show no substitutions within the clades, consequently no differential inferences may be made regarding their influence on ACE levels. The presence of residual familial correlations that are not accounted for by the ACE-linked QTL was strongly supported in our analyses. These residual correlations are compatible with the presence of an unlinked genetic factor(s) consistent with our previous findings based on a different population (12) .
Sequential examination of individual polymorphisms within a gene or region of interest in an attempt to narrow the region in which a causative variant may be found is fraught with problems of interpretation. For correct inferences to be drawn, disequilibrium models need to be correctly specified in terms of the number of variants, which is impossible to verify until the exact nature of the quantitative variation is known. Also, the dimensionality of disequilibrium models increases exponentially with the number of polymorphisms and variants in the model and strategies to reduce the complexity of the analytical problem are desirable. Haplotype-based analyses summarize linkage disequilibrium relationships and provide a natural approach to mapping quantitative variation onto genetic diversity that is biologically appealing. To this end, Templeton and colleagues (for a recent review see ref. 16 ) have investigated cladistic methodologies in the study of quantitative variation. They argue that mutations that influence traits have arisen during the evolutionary history of the set of polymorphisms that are associated with the trait. Consequently, it is expected that members of clades of haplotypes will resemble each other phenotypically and the overall haplotype cladogram will be useful in devising powerful statistical tests to distinguish the most important mutations. Using data sets for Drosophila traits, Templeton and Sing (17) have shown how useful recombination can be to refine the physical localization of phenotype-modifying mutations. Here we have adopted these methods to the analysis of a human quantitative trait with no prior assumptions regarding the number or location of the underlying variants. Our method takes full advantage of the opportunity offered by a simple haplotype cladogram with one clade derived from an ancestral recombination event.
Sequencing of the seven introns between the T-93C and T1237C polymorphisms will be required to identify further polymorphisms, which will refine the localization of the ancestral breakpoint and will also characterize the variant(s) lying downstream of the T-93C polymorphism that influences ACE levels. Sequencing studies in other populations with different (recent) evolutionary histories may reveal alternative polymorphisms, breakpoints and cladograms that may refine the localization of the major variant(s) influencing ACE levels. These approaches will be necessary to identify a limited number of candidate variants in the ACE gene, which will require examination in biological assays in order to establish their functional significance. 
MATERIALS AND METHODS
Families and ACE trait
Eighty-three extended families with between four and 18 members were collected through an established project (HTO) to investigate the genetic basis of blood pressure variability and cardiovascular risk factor status in the British white population (18) . The Central Oxford Research Ethics Committee approved the protocol for collection of the families. Plasma ACE activity was measured by HPLC with the use of a synthetic substrate (19) . All samples from one family were assayed in a single run; each sample was analysed in duplicate and re-analysed if the two analyses differed by >15%. A preliminary correlational analysis found no evidence of an association between plasma ACE levels and systolic blood pressure (ρ = 0.0013, P = 0.98) or diastolic blood pressure (ρ = -0.045, P = 0.45); consequently no ascertainment correction was made in analyses of plasma ACE levels. Plasma ACE levels were standardized separately for males and females to account for a small but significant (P < 0.05) difference. ACE levels showed no significant relationship with age and/or body mass index. Ages of family members ranged from 19 to 90 years.
Genotyping
DNA was extracted using standard methods (20) . The I/D polymorphism at the ACE locus was typed using a PCR-based method (21) . A further nine polymorphisms, T-5991C, A-5466C, T-3892C, A-240T, T-93C, T1237C, G2215A, G2350A and 4656(CT) 3/2 , that were originally described by Villard et al. (13) , were genotyped following PCR amplification (Table 4) . Further PCR experimental details may be found on a World Wide Web page (http://www.well.ox.ac.uk/mfarrall/ACE_polymorphisms. html ). The genomic location of each polymorphism is shown with respect to ACE exonic sequences in Figure 1 .
Haplotype assignment
The SIMWALK program (14) ab initio finds a set of (possibly recombinant) haplotypes that are consistent with the family structure and the multilocus genotypic data. The program then performs simulated annealing, a combinatorial optimization procedure, to search for more likely states with fewer recombinant haplotypes and terminates immediately on finding a non-recombinant haplotype state. By initiating SIMWALK with different random seeds in a pedigree, one may obtain replicates that are a random sample from the space of all possible underlying haplotype configurations. In SIMWALK, equal allele frequencies at each site were assumed, so that the frequency with which different haplotype configurations (haplotype sets) emerge in the simulation would depend only on the pattern of genotype data and relationships in that family. After many replicate haplotype sets were produced for each family, maximum likelihood estimates of the haplotype frequencies were computed based on a gene counting or expectation maximization (EM) algorithm (22, 23) , similar to that used for random samples from diploid populations (24) . Briefly, equal or other arbitrary values were assumed as initial haplotype frequency estimates. New estimates were obtained by weighting each haplotype set from the simulation by the frequency estimates applied to the founders. The weighted haplotype frequencies in founding pedigree members were calculated and used as new estimates in the EM procedure. Iterations were continued until the estimates converged. Haplotype sets for each family were then tabulated with their final probabilities. Unfavourable sets associated with very small probabilities (<10 -6 ) were discarded, with no effect on subsequent analyses. Exact significance tests for sparse contingency table analyses were performed using the computer program CoCo 1.3.R2 obtained by anonymous ftp from the server ftp.math.auc.dk (25) .
Measured haplotype analysis
Likelihood calculations were performed using a modified version of the Pedigree Analysis Package (PAP) v.4.02 (26, 27) . The PAP FORTRAN subroutine qmlprmv, which models major quantitative traits, was modified to include a parameter to model the mean effect on the ACE trait for each haplotype; these effects were assumed to act additively (i.e. co-dominant inheritance). A single parameter was specified to model the residual genotype-specific variation. Residual familial correlations were accounted for by a class D regressive model that includes spouse, mother-offspring, father-offspring and sibling correlations (15) . The most general model [1, 2, 3, 4, 5, 6, 7 ,X] therefore includes a total of 20 parameters, seven haplotype frequencies, eight mean effects, one residual standard deviation and four to model residual familial correlations. The main likelihood computing subroutine in PAP, paplk, was modified to calculate the overall likelihood of a family as a sum of likelihood terms computed for each alternative haplotype set. The goodness-of-fit of nested models was evaluated using likelihood ratio tests, where the difference in -2 log e likelihood between models is assumed to be asymptotically distributed as a χ 2 statistic with degrees of freedom equal to the difference in number of parameters fitted in the two models. The choice of which model comparisons will be the most informative is difficult and should be postponed until a preliminary analysis of the haplotypes, without reference to the quantitative trait, has been completed. For example, it may be possible to reconstruct a plausible cladogram that summarizes the evolutionary relationships between haplotypes. The impact on the goodness-of-fit resulting from pooling the effects of closely related haplotypes (clade members) provides a natural series of tests. The superimposition of an ancestral recombination breakpoint on the haplotype cladogram allows tests between different clades in order to map the quantitative variation with respect to the breakpoint.
